Figure 4From: Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injuryRenal morphology by PAS staining. ARA290 preserved renal morphology. In controls massive tubular dilatation, -necrosis and -debris was observed (A). Especially, early ARA290 treatment resulted in a distinct reduction of tubular damage (B). Late- (C) and repetitive treatment (D) slightly reduced renal damage.Back to article page